CRISPR activation screens identify oncogenic lncRNAs that are susceptible to CDK4/6 inhibitor treatment

Y Yifei Wang Y Yueshan Zhao J Jiaxin Hu Z Zehua Wang (Department of Physics and Astronomy and the IQ Initiative) D Dhamotharan Pattarayan S Sihan Li (Division of Ribonucleic Acid (RNA) and Gene Regulation, Institute of Medical Science, The University of Tokyo) Y Yu Zhang (Xiangya Hospital, Central South University Changsha China) X Xiaofei Wang (College of Chemistry and Molecular Sciences, Wuhan University, Wuhan 430072, China) Y Yue Wang W Wen Xie M Min Zhang D Da Yang

Article Details

Volume / Issue Vol. 17, Issue 1
Published April 09, 2026
ISSN 2041-1723
Publisher Nature Portfolio

Journal Info

Nature Communications

Nature Portfolio

ISSN: 2041-1723 Open Access Life Sciences

Authors (12)

Y

Yifei Wang

Y

Yueshan Zhao

J

Jiaxin Hu

Z

Zehua Wang

Department of Physics and Astronomy and the IQ Initiative

D

Dhamotharan Pattarayan

S

Sihan Li

Division of Ribonucleic Acid (RNA) and Gene Regulation, Institute of Medical Science, The University of Tokyo

Y

Yu Zhang

Xiangya Hospital, Central South University Changsha China

X

Xiaofei Wang

College of Chemistry and Molecular Sciences, Wuhan University, Wuhan 430072, China

Y

Yue Wang

W

Wen Xie

M

Min Zhang

D

Da Yang